Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

Posted on by

TUCSON, Ariz., Jan. 19, 2024 /PRNewswire/ — Accelerate Diagnostics, Inc. (NASDAQ: AXDX) (the “Company”) today announced the pricing of an underwritten public offering consisting of 6,860,659 units, each consisting of one share of common stock and one warrant to purchase one share of…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.